IRIS Accounts Production v24.2.0.383 10246838 Board of Directors Board of Directors 1.1.23 31.12.23 31.12.23 sale of pharmaceutical products and investments in subsidiaries. 0 0 false true false false true false 0 0 Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh102468382022-12-31102468382023-12-31102468382023-01-012023-12-31102468382021-12-31102468382022-01-012022-12-31102468382022-12-3110246838ns15:EnglandWales2023-01-012023-12-3110246838ns14:PoundSterling2023-01-012023-12-3110246838ns10:Director12023-01-012023-12-3110246838ns10:Director22023-01-012023-12-3110246838ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3110246838ns10:SmallEntities2023-01-012023-12-3110246838ns10:AuditExemptWithAccountantsReport2023-01-012023-12-3110246838ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3110246838ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3110246838ns10:FullAccounts2023-01-012023-12-3110246838ns10:OrdinaryShareClass12023-01-012023-12-3110246838ns10:RegisteredOffice2023-01-012023-12-3110246838ns5:CurrentFinancialInstruments2023-12-3110246838ns5:CurrentFinancialInstruments2022-12-3110246838ns5:ShareCapital2023-12-3110246838ns5:ShareCapital2022-12-3110246838ns5:RetainedEarningsAccumulatedLosses2023-12-3110246838ns5:RetainedEarningsAccumulatedLosses2022-12-3110246838ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3110246838ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3110246838ns10:OrdinaryShareClass12023-12-3110246838ns5:RetainedEarningsAccumulatedLosses2022-12-3110246838ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-31
















NEILMED HOLDING COMPANY LIMITED

REPORT OF THE DIRECTORS AND

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023






NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023




Page

Company Information 1

Report of the Directors 2

Income Statement 3

Balance Sheet 4

Notes to the Financial Statements 5


NEILMED HOLDING COMPANY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTORS: Dr K Mehta
Ms. N Mehta





REGISTERED OFFICE: 221 Kenton Lane
Kenton
Harrow
Middlesex
HA3 8RP





REGISTERED NUMBER: 10246838 (England and Wales)





ACCOUNTANTS: Akshar & Company
Chartered Accountants
221 Kenton Lane
Harrow
Middlesex
HA3 8RP

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2023

The directors present their report with the financial statements of the company for the year ended 31 December 2023.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2023 to the date of this report.

Dr K Mehta
Ms. N Mehta

DIRECTORS' RESPONSIBILITIES STATEMENT
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Dr K Mehta - Director


25 September 2024

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

INCOME STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2023

2023 2022
£    £   

TURNOVER - -

Administrative expenses 55,312 (197,454 )
OPERATING (LOSS)/PROFIT and
(LOSS)/PROFIT BEFORE TAXATION (55,312 ) 197,454

Tax on (loss)/profit (10,509 ) 32,381
(LOSS)/PROFIT FOR THE FINANCIAL YEAR (44,803 ) 165,073

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
Notes £    £   
CURRENT ASSETS
Debtors 4 1,150,970 1,206,170
Investments 5 6,643 6,643
Cash at bank and in hand 17,542 17,654
1,175,155 1,230,467
CREDITORS
Amounts falling due within one year 6 (3,866 ) 6,643
NET CURRENT ASSETS 1,179,021 1,223,824
TOTAL ASSETS LESS CURRENT LIABILITIES 1,179,021 1,223,824

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 8 1,178,921 1,223,724
SHAREHOLDERS' FUNDS 1,179,021 1,223,824

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 25 September 2024 and were signed on its behalf by:




Dr K Mehta - Director



Ms. N Mehta - Director


NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1. STATUTORY INFORMATION

Neilmed Holding Company Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 1,150,970 1,206,170

5. CURRENT ASSET INVESTMENTS
2023 2022
£    £   
Shares in group undertakings 6,643 6,643

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Amounts owed to group undertakings 6,643 6,643
Taxation and social security (10,509 ) -
(3,866 ) 6,643

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100

8. RESERVES
Retained
earnings
£   

At 1 January 2023 1,223,724
Deficit for the year (44,803 )
At 31 December 2023 1,178,921